Oral Diabetes Medicines Information
More articles below:
Wounded Soldier Spared Diabetes With Emergency Transplant
Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality
Hormones Tied to Diabetes Might Also Influence Fertility
Kids Need Parents' Help in Managing Type 1 Diabetes
Many Americans Unaware They Have Chronic Kidney Disease
Researchers Identify 2 Genes Linked to Fatty Liver Disease
Home glucose monitoring is the cornerstone of every diabetes management program. It allows the diabetic to learn and follow the day to day changes in their blood sugars and, in partnership with their physician, make any necessary changes in their treatment plan.
Periodically following up with a registered dietician can help to establish a successful, “carbohydrate-based” eating plan.
Regularly scheduled meals and physical activity can help to avoid fluctuations in blood sugar while, at the same time, improving overall blood sugar control.
It is imperative that the diabetic develop a safe, effective exercise prescription in conjunction with their physician.
Type 2 Diabetes Drug May Increase Fracture Risk
MONDAY, Sept. 28 (HealthDay News) -- Patients who take the diabetes drugs known as thiazolidinediones may be at higher risk of bone fracture, new research suggests.
In the study, Dr. Ian Douglas of the London School of Hygiene and Tropical Medicine and colleagues searched a database of more than 6 million patients in the United Kingdom and found 1,819 people aged 40 and older who had had a bone fracture and had been prescribed a type of thiazolidinedione. The drugs were introduced in the 1990s and are used to treat type 2 diabetes.
After adjusting their figures to account for the fact that older people are more likely to break bones, the researchers found that those taking thiazolidinediones had almost 1.5 times as many fractures while taking the drugs as they did when they weren't taking the drugs. The risk grew the longer the people took the medications.
The findings support previous research that has suggested a link between these medications and bone fractures. But the researchers acknowledge that the study didn't follow the gold standard of research, which is to randomly assign people to take the drug or not take it.
Still, Douglas and colleagues conclude that the findings "should be taken into consideration in the wider debate surrounding the possible risks and benefits of treatment with thiazolidinediones."
The study appears in the Sept. 29 online edition of the journal PLoS Medicine.
More information
Learn more about diabetes from the American Diabetes Association.
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
